Correlation Between ANT and Amicus Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ANT and Amicus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ANT and Amicus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ANT and Amicus Therapeutics, you can compare the effects of market volatilities on ANT and Amicus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ANT with a short position of Amicus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ANT and Amicus Therapeutics.

Diversification Opportunities for ANT and Amicus Therapeutics

-0.14
  Correlation Coefficient

Good diversification

The 3 months correlation between ANT and Amicus is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding ANT and Amicus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amicus Therapeutics and ANT is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ANT are associated (or correlated) with Amicus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amicus Therapeutics has no effect on the direction of ANT i.e., ANT and Amicus Therapeutics go up and down completely randomly.

Pair Corralation between ANT and Amicus Therapeutics

Assuming the 90 days trading horizon ANT is expected to generate 22.57 times more return on investment than Amicus Therapeutics. However, ANT is 22.57 times more volatile than Amicus Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Amicus Therapeutics is currently generating about -0.01 per unit of risk. If you would invest  281.00  in ANT on November 2, 2024 and sell it today you would lose (134.00) from holding ANT or give up 47.69% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy60.32%
ValuesDaily Returns

ANT  vs.  Amicus Therapeutics

 Performance 
       Timeline  
ANT 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in ANT are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, ANT exhibited solid returns over the last few months and may actually be approaching a breakup point.
Amicus Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Amicus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

ANT and Amicus Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ANT and Amicus Therapeutics

The main advantage of trading using opposite ANT and Amicus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ANT position performs unexpectedly, Amicus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amicus Therapeutics will offset losses from the drop in Amicus Therapeutics' long position.
The idea behind ANT and Amicus Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities